© Munic Security Conference 2018 Eric Schmidt (r) Kofi Annan (l)Google buys into European competitors' ecosystem

March 2018. Alphabet Inc. (“Google”) aims at two birds with one stone. The company needs more than ever goodwill of European policymakers and industry in order to counter the backlash against "America First" policies and growing public distrust in neutral platform operations by U.S. social media companies. Alphabet's second largest revenue stream comes from Europe, and here profitability of its "bets" critically depends on access to talent, infrastructures needed for autonomous transportation as well as a receptive environment for big data harvesting.

Mid-February Eric Schmidt, Alphabet's former Chairman and now Board Member participated in the Munich Security Conference (MSC). He joined Microsoft and Facebook in a wider charming initiative of the U.S. information industry targeting EU policymakers and influencers who are responding to cases of outright contempt for national or EU regulations, stateless operations of digital platforms, or tax evasion schemes. The move comes at a time when these companies are struggling with increased political pressure at home.

During his visit Mr. Schmidt also attended a ceremony to celebrate a partnership between Google's Bavarian © Wolf G Kroner 2018 Google last one to join the ecosystem Tech Center and the Technical University Munich. TUM rector Herrmann slipped into the exchange of courtesies repeated reminders that this collaboration is on an equal basis. The university acts for Google's bets as a door opener to an ecosystem which includes several of the company's strongest competitors.

You may access full live recordings of Eric Schmidt's intervention during MSC in YouTube or look up TUM press releases free of charge. However, if you like to get an independent assessment, deeper background or reactions to Google penetrating the "Isar Valley" you can read the article of B2Bioworld and purchase it now.

Please notice, If you order by email from an organisation - for-profit or nonprofit alike - you must buy an organisation sharing license and cannot buy an individual license. However the organisation sharing license entitles you to share the article with up to four other individuals - provided you adhere to the Terms and Conditions which you agree with when purchasing articles of B2Bioworld.

Article free of advertisement

Full Company License enquire here

Back to section

Related Editorial Articles

B2Bioworld offers you background information

Regulatory Challenges of Big Data Operations – Algorithms, Healthcare, or Autonomous Driving
Herbert Zech, Professor of Life Sciences and Intellectual Property Laws at Universität Basel on key juridical concepts of the current debate about big data and artificial intelligence applications beyond privacy laws

Expansion of the global commercial vehicle market

“Grande gueule” and the fallout of Brexit, CETA, or Trumpeta
Jan Peumans, President of the Belgium’s Flemish Parliament about regional politics in uncertain times for international trade

Physics <> Information <> Biology
A view from quantum optics. Alain Aspect, Professor of Physics at Institut d’Optique and Balzan Prize winner

Roche prepares for user innovation
I can imagine a shift and additions in skill sets, predicts Ursula Redeker, CEO of Roche Germany

Synthetic Genomics: Autochthon Biotechnology
Business Strategies for Food, Feed, and Biofuels from Algae. James H Flatt, Chief Technology Officer Synthetic Genomics

European and U.S. Codes of Conduct for Development of Robotics and Artificial Intelligence

Seiko Epson and its Business Perspectives
Venturing into robotics, drones, microfluidics, and other AI – device developments. Includes an interview with Minoru Usui, CEO SeikoEpson

Yamaha’s Flex-Fuel Criss-Crosser
Brazilian DNA to Re-program Honda Moto

De-mystifying Corruption: Identifying, Sanctioning, Monitoring, Preventing

Steering Health Data For or By?
The User as Stakeholder, Expert, Citizen, Consumer, and Patient. Thomas Szucs, Chairman of Swiss Helsana Group

Systems Biology Applied
Rudi Balling, Director of the Luxembourg Centre for Systems Biomedicine, on the need of systems theory thinking in using technologies and pitfalls of some concepts